APA (7th ed.) Citation

Topaly, J., Frühauf, S., Ho, A. D., & Zeller, W. J. (2002). Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: Implications for pretransplant conditioning. British journal of cancer, 86(9), . https://doi.org/10.1038/sj.bjc.6600242

Chicago Style (17th ed.) Citation

Topaly, Julian, Stefan Frühauf, Anthony Dick Ho, and W. Jens Zeller. "Rationale for Combination Therapy of Chronic Myelogenous Leukaemia with Imatinib and Irradiation or Alkylating Agents: Implications for Pretransplant Conditioning." British Journal of Cancer 86, no. 9 (2002). https://doi.org/10.1038/sj.bjc.6600242.

MLA (9th ed.) Citation

Topaly, Julian, et al. "Rationale for Combination Therapy of Chronic Myelogenous Leukaemia with Imatinib and Irradiation or Alkylating Agents: Implications for Pretransplant Conditioning." British Journal of Cancer, vol. 86, no. 9, 2002, https://doi.org/10.1038/sj.bjc.6600242.